The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Puma Biotechnology Inc shares valued at $81,466 were sold by MILLER MICHAEL PATRICK on Aug 12 ’24. At $3.49 per share, MILLER MICHAEL PATRICK sold 23,358 shares. The insider’s holdings dropped to 47,000 shares worth approximately $0.15 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, MILLER MICHAEL PATRICK purchased 23,358 shares, netting a total of over 87,826 in proceeds.
Before that, NOUGUES MAXIMO F had sold 4,156 shares from its account. In a trade valued at $15,382, the Chief Financial Officer traded Puma Biotechnology Inc shares for $3.70 each. Upon closing the transaction, the insider’s holdings decreased to 4,156 shares, worth approximately $0.51 million.
As published in a research note from Citigroup on September 28, 2021, Puma Biotechnology Inc [PBYI] has been rated up from a Neutral to a Buy and the price target has been revised to $11. As of October 08, 2019, Goldman has decreased its “Neutral” rating to a “Sell” for PBYI. Earlier on May 10, 2019, Citigroup downgraded its rating. Their new recommendation was “a Neutral” for PBYI stock which previously was a “a Buy”.
Analyzing PBYI Stock Performance
During the last five days, there has been a surge of approximately 13.72%. Over the course of the year, Puma Biotechnology Inc shares have dropped approximately -27.25%. Shares of the company reached a 52-week high of $7.73 on 02/15/24 and a 52-week low of $2.22 on 09/06/24. A 50-day SMA is recorded $2.95, while a 200-day SMA reached $3.55. Nevertheless, trading volume fell to 1.13 million shares from 0.9 million shares the previous day.
Support And Resistance Levels for Puma Biotechnology Inc (PBYI)
According to the 24-hour chart, there is a support level at 2.93, which, if violated, would cause prices to drop to 2.70. In the upper region, resistance lies at 3.34. The next price resistance is at 3.52. RSI (Relative Strength Index) is 57.39 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.06, which suggests the price will decrease in the coming days. Percent R is at 25.86%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
